Brad Stewart
Market Managing Principal; Life Sciences National Leader
Executive Summary
Brad is a growth architect who led creation / turnaround, and growth of multiple global entities. He established dynamic and collaborative leadership teams to ensure organizational success. He is a pioneering thought leader who drives entrepreneurship, diversity, inclusion, financial success, technology transfer, and workforce development.
Brad is a relentless achiever with intellectual curiosity and rare determination to master the details, design strategic solutions, and execute exceptionally for sustainable top- and bottom-line results. He is successful regardless of challenges.
Corporate Milestones:
- Cylex, Inc.: Maximized shareholder ROI – delivered cash returns >4X initial offer. Executed strategic sale process resulting in purchase price of 2.6X sales and two M&A Deal of the Year nominations.
- BearingPoint, Inc.: Identified >$200MM EBITDA improvement (12.6% of net sales) via strategic restructuring for Bayer Pharmaceuticals.
- Sigma-Tau: Increased profits 38.7%, sales 24.6%, and EBITDA by $40MM.
Additionally, Brad founded a global company and closed $100MM joint-venture deal. His focus areas include:
- Vision, Strategy & Execution
- Operational Leadership
- Value Creation
- Intellectual Property
- Portfolio Development
- Commercialization
- Mergers & Acquisitions
- Organizational Restructuring
- Strategic Negotiations
- Financial Turnaround
- Joint Venture Development
- Maximizing Investor Return